2015
DOI: 10.1155/2015/249617
|View full text |Cite
|
Sign up to set email alerts
|

Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature

Abstract: Deferoxamine mesylate (DFO) is the most commonly used iron-chelating agent to treat transfusion-related hemosiderosis. Despite the clear advantages for the use of DFO, numerous DFO-related systemic toxicities have been reported in the literature, as well as sight-threatening ocular toxicity involving the retinal pigment epithelium (RPE). The damage to the RPE can lead to visual field defects, color-vision defects, abnormal electrophysiological tests, and permanent visual deterioration. The purpose of this revi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
52
0
7

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(60 citation statements)
references
References 45 publications
1
52
0
7
Order By: Relevance
“…The invisibility effect on the contour conditions of excess iron could be caused by the delayed effect where the excess iron accumulated in the organs and tissues of the body were not directly visible but were accumulative and could appear in the long term [15]. In coherence with literature, damage or deterioration of liver function are sometimes not visible on the morphological structure of the liver and could be observed on the histological structure of liver [16].…”
Section: Morphometry Of Liversupporting
confidence: 53%
“…The invisibility effect on the contour conditions of excess iron could be caused by the delayed effect where the excess iron accumulated in the organs and tissues of the body were not directly visible but were accumulative and could appear in the long term [15]. In coherence with literature, damage or deterioration of liver function are sometimes not visible on the morphological structure of the liver and could be observed on the histological structure of liver [16].…”
Section: Morphometry Of Liversupporting
confidence: 53%
“…It has a systemic toxicity effect on the cardiovascular, respiratory, gastrointestinal, cutaneous, and nervous systems. Bone dysplasia and high-frequency sensory neuronal hearing loss have been reported 1 . As to ocular toxicity, desferrioxamine can cause nyctalopia, abnormal color perception, visual field defects, cataract formation, optic neuropathy, and pigmentary retinopathy.…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, their use may lead to ocular toxicity, presenting in the form of a deterioration in visual acuity and color vision, night blindness, a scotoma or constricted visual field, retinopathy, optic neuropathy, and an abnormal retinal function detectable by electroretinogram (ERG). [1][2][3][4][5] Little information has been reported on the incidences of these ocular toxicities, and there are no standard eye-screening guidelines for patients.…”
Section: Introductionmentioning
confidence: 99%
“…DFO is most commonly administered as a slow subcutaneous infusion but can also be given intramuscularly or intravenously [49]. Ocular findings of DFO toxicity include cataract, optic neuropathy and retinopathy [50,51,52]. Retinal abnormalities include macular and peripheral pigmentary changes, retinal pigment epithelium degenerations and bull's eye maculopathy [53,54,55].…”
Section: Deferoxamine Retinopathymentioning
confidence: 99%